Bayesian Capital Management, LP Emergent Bio Solutions Inc. Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $491,511 - $713,583	-5,700 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $133,084 - $187,381	1,681 Added 41.83%	5,700 $511,000
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $329,196 - $542,323	4,019 New	4,019 $415,000
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $160,159 - $216,086	-4,012 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $193,498 - $265,433	4,012 New	4,012 $203,000
Q1 2018 May 15, 2018	SELL	$44.44 - $54.39 $448,132 - $548,468	-10,084 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$37.77 - $47.75 $380,872 - $481,511	10,084	10,084 $469,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.